SynthesisPloS one2021

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review.

Sudpreeda Chainitikun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.